Filtros : "FCF004" "Journal of Pharmaceutical and Biomedical Analysis" Removidos: "TRABALHO DE EVENTO-RESUMO" "PSICOLOGIA" "Oliveira, George Gualberto Gualter de" "Kedor-Hackmann, Erika Rosa Maria" "Singh, Anil Kumar" Limpar

Filtros



Refine with date range


  • Source: Journal of Pharmaceutical and Biomedical Analysis. Unidade: FCF

    Subjects: INDÚSTRIA FARMACÊUTICA, CROMATOGRAFIA LÍQUIDA

    PrivadoAcesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      PASSARIN, Paula Beatriz Silva e LOURENÇO, Felipe Rebello. Enhancing analytical development in the pharmaceutical industry: a DoE-QSRR model for virtual method operable design region assessment. Journal of Pharmaceutical and Biomedical Analysis, v. 239, p. 1-12, 2024Tradução . . Disponível em: https://dx.doi.org/10.1016/j.jpba.2023.115907. Acesso em: 24 jun. 2024.
    • APA

      Passarin, P. B. S., & Lourenço, F. R. (2024). Enhancing analytical development in the pharmaceutical industry: a DoE-QSRR model for virtual method operable design region assessment. Journal of Pharmaceutical and Biomedical Analysis, 239, 1-12. doi:10.1016/j.jpba.2023.115907
    • NLM

      Passarin PBS, Lourenço FR. Enhancing analytical development in the pharmaceutical industry: a DoE-QSRR model for virtual method operable design region assessment [Internet]. Journal of Pharmaceutical and Biomedical Analysis. 2024 ; 239 1-12.[citado 2024 jun. 24 ] Available from: https://dx.doi.org/10.1016/j.jpba.2023.115907
    • Vancouver

      Passarin PBS, Lourenço FR. Enhancing analytical development in the pharmaceutical industry: a DoE-QSRR model for virtual method operable design region assessment [Internet]. Journal of Pharmaceutical and Biomedical Analysis. 2024 ; 239 1-12.[citado 2024 jun. 24 ] Available from: https://dx.doi.org/10.1016/j.jpba.2023.115907
  • Source: Journal of Pharmaceutical and Biomedical Analysis. Unidade: FCF

    Subjects: MEDICAMENTO, MÉTODO DE MONTE CARLO, MEDIÇÃO DE RISCO

    PrivadoAcesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      MARTINS, Maisa Torres e LOURENÇO, Felipe Rebello. Measurement uncertainty for < 905 > Uniformity of Dosage Units tests using Monte Carlo and bootstrapping methods – Uncertainties arising from sampling and analytical steps. Journal of Pharmaceutical and Biomedical Analysis, v. 238, p. 1-8 art. 115857, 2024Tradução . . Disponível em: https://dx.doi.org/10.1016/j.jpba.2023.115857. Acesso em: 24 jun. 2024.
    • APA

      Martins, M. T., & Lourenço, F. R. (2024). Measurement uncertainty for < 905 > Uniformity of Dosage Units tests using Monte Carlo and bootstrapping methods – Uncertainties arising from sampling and analytical steps. Journal of Pharmaceutical and Biomedical Analysis, 238, 1-8 art. 115857. doi:10.1016/j.jpba.2023.115857
    • NLM

      Martins MT, Lourenço FR. Measurement uncertainty for < 905 > Uniformity of Dosage Units tests using Monte Carlo and bootstrapping methods – Uncertainties arising from sampling and analytical steps [Internet]. Journal of Pharmaceutical and Biomedical Analysis. 2024 ; 238 1-8 art. 115857.[citado 2024 jun. 24 ] Available from: https://dx.doi.org/10.1016/j.jpba.2023.115857
    • Vancouver

      Martins MT, Lourenço FR. Measurement uncertainty for < 905 > Uniformity of Dosage Units tests using Monte Carlo and bootstrapping methods – Uncertainties arising from sampling and analytical steps [Internet]. Journal of Pharmaceutical and Biomedical Analysis. 2024 ; 238 1-8 art. 115857.[citado 2024 jun. 24 ] Available from: https://dx.doi.org/10.1016/j.jpba.2023.115857
  • Source: Journal of Pharmaceutical and Biomedical Analysis. Unidade: FCF

    Subjects: CROMATOGRAFIA LÍQUIDA DE ALTA EFICIÊNCIA, MÉTODO DE MONTE CARLO, FÁRMACOS (SISTEMA REPRODUTOR)

    PrivadoAcesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      SILVA, Fernando Antunes da e LOURENÇO, Felipe Rebello e CALIXTO, Leandro Augusto. Development and optimization of stability-indicating method of ethinylestradiol, levonorgestrel, and their main impurities using quality by design approach. Journal of Pharmaceutical and Biomedical Analysis, v. 225, p. 1-14 art. 115208, 2023Tradução . . Disponível em: https://doi.org/10.1016/j.jpba.2022.115208. Acesso em: 24 jun. 2024.
    • APA

      Silva, F. A. da, Lourenço, F. R., & Calixto, L. A. (2023). Development and optimization of stability-indicating method of ethinylestradiol, levonorgestrel, and their main impurities using quality by design approach. Journal of Pharmaceutical and Biomedical Analysis, 225, 1-14 art. 115208. doi:10.1016/j.jpba.2022.115208
    • NLM

      Silva FA da, Lourenço FR, Calixto LA. Development and optimization of stability-indicating method of ethinylestradiol, levonorgestrel, and their main impurities using quality by design approach [Internet]. Journal of Pharmaceutical and Biomedical Analysis. 2023 ; 225 1-14 art. 115208.[citado 2024 jun. 24 ] Available from: https://doi.org/10.1016/j.jpba.2022.115208
    • Vancouver

      Silva FA da, Lourenço FR, Calixto LA. Development and optimization of stability-indicating method of ethinylestradiol, levonorgestrel, and their main impurities using quality by design approach [Internet]. Journal of Pharmaceutical and Biomedical Analysis. 2023 ; 225 1-14 art. 115208.[citado 2024 jun. 24 ] Available from: https://doi.org/10.1016/j.jpba.2022.115208
  • Source: Journal of Pharmaceutical and Biomedical Analysis. Unidade: FCF

    Subjects: MEDICAMENTO, MEDIÇÃO DE RISCO, ANÁLISE MULTIVARIADA

    PrivadoAcesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      SILVA, Cintia Margueiro da e LOURENÇO, Felipe Rebello. Definition of multivariate acceptance limits (guard-bands) applied to pharmaceutical equivalence assessment. Journal of Pharmaceutical and Biomedical Analysis, v. 222, p. 1-7 art. 115080, 2023Tradução . . Disponível em: https://doi.org/10.1016/j.jpba.2022.115080. Acesso em: 24 jun. 2024.
    • APA

      Silva, C. M. da, & Lourenço, F. R. (2023). Definition of multivariate acceptance limits (guard-bands) applied to pharmaceutical equivalence assessment. Journal of Pharmaceutical and Biomedical Analysis, 222, 1-7 art. 115080. doi:10.1016/j.jpba.2022.115080
    • NLM

      Silva CM da, Lourenço FR. Definition of multivariate acceptance limits (guard-bands) applied to pharmaceutical equivalence assessment [Internet]. Journal of Pharmaceutical and Biomedical Analysis. 2023 ; 222 1-7 art. 115080.[citado 2024 jun. 24 ] Available from: https://doi.org/10.1016/j.jpba.2022.115080
    • Vancouver

      Silva CM da, Lourenço FR. Definition of multivariate acceptance limits (guard-bands) applied to pharmaceutical equivalence assessment [Internet]. Journal of Pharmaceutical and Biomedical Analysis. 2023 ; 222 1-7 art. 115080.[citado 2024 jun. 24 ] Available from: https://doi.org/10.1016/j.jpba.2022.115080
  • Source: Journal of Pharmaceutical and Biomedical Analysis. Unidade: FCF

    Subjects: MEDICAMENTO, MEDIÇÃO DE RISCO, BIOEQUIVALÊNCIA, QUALIDADE DOS MEDICAMENTOS

    PrivadoAcesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      BERTANHA, Maria Luiza de Godoy e LOURENÇO, Felipe Rebello. Risk of false pharmaceutical equivalence (non-equivalence) decisions due to measurement uncertainty. Journal of Pharmaceutical and Biomedical Analysis, v. 204, p. 1-9 art. 114269, 2021Tradução . . Disponível em: https://doi.org/10.1016/j.jpba.2021.114269. Acesso em: 24 jun. 2024.
    • APA

      Bertanha, M. L. de G., & Lourenço, F. R. (2021). Risk of false pharmaceutical equivalence (non-equivalence) decisions due to measurement uncertainty. Journal of Pharmaceutical and Biomedical Analysis, 204, 1-9 art. 114269. doi:10.1016/j.jpba.2021.114269
    • NLM

      Bertanha ML de G, Lourenço FR. Risk of false pharmaceutical equivalence (non-equivalence) decisions due to measurement uncertainty [Internet]. Journal of Pharmaceutical and Biomedical Analysis. 2021 ; 204 1-9 art. 114269.[citado 2024 jun. 24 ] Available from: https://doi.org/10.1016/j.jpba.2021.114269
    • Vancouver

      Bertanha ML de G, Lourenço FR. Risk of false pharmaceutical equivalence (non-equivalence) decisions due to measurement uncertainty [Internet]. Journal of Pharmaceutical and Biomedical Analysis. 2021 ; 204 1-9 art. 114269.[citado 2024 jun. 24 ] Available from: https://doi.org/10.1016/j.jpba.2021.114269
  • Source: Journal of Pharmaceutical and Biomedical Analysis. Unidade: FCF

    Assunto: CROMATOGRAFIA LÍQUIDA

    Acesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      SEPAROVIC, Luciana e LOURENÇO, Felipe Rebello. Frequentist approach for estimation of false decision risks in conformity assessment based on measurement uncertainty of liquid chromatography analytical procedures. Journal of Pharmaceutical and Biomedical Analysis, v. 184, p. 1-7 art. 113203, 2020Tradução . . Disponível em: https://doi.org/10.1016/j.jpba.2020.113203. Acesso em: 24 jun. 2024.
    • APA

      Separovic, L., & Lourenço, F. R. (2020). Frequentist approach for estimation of false decision risks in conformity assessment based on measurement uncertainty of liquid chromatography analytical procedures. Journal of Pharmaceutical and Biomedical Analysis, 184, 1-7 art. 113203. doi:10.1016/j.jpba.2020.113203
    • NLM

      Separovic L, Lourenço FR. Frequentist approach for estimation of false decision risks in conformity assessment based on measurement uncertainty of liquid chromatography analytical procedures [Internet]. Journal of Pharmaceutical and Biomedical Analysis. 2020 ; 184 1-7 art. 113203.[citado 2024 jun. 24 ] Available from: https://doi.org/10.1016/j.jpba.2020.113203
    • Vancouver

      Separovic L, Lourenço FR. Frequentist approach for estimation of false decision risks in conformity assessment based on measurement uncertainty of liquid chromatography analytical procedures [Internet]. Journal of Pharmaceutical and Biomedical Analysis. 2020 ; 184 1-7 art. 113203.[citado 2024 jun. 24 ] Available from: https://doi.org/10.1016/j.jpba.2020.113203
  • Source: Journal of Pharmaceutical and Biomedical Analysis. Unidade: FCF

    Subjects: CROMATOGRAFIA LÍQUIDA, MÉTODO DE MONTE CARLO

    Acesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      SEPAROVIC, Luciana e LOURENÇO, Felipe Rebello. Measurement uncertainty and risk of false conformity decision in the performance evaluation of liquid chromatography analytical procedures. Journal of Pharmaceutical and Biomedical Analysis, v. 171, p. 73-80, 2019Tradução . . Disponível em: https://doi.org/10.1016/j.jpba.2019.04.005. Acesso em: 24 jun. 2024.
    • APA

      Separovic, L., & Lourenço, F. R. (2019). Measurement uncertainty and risk of false conformity decision in the performance evaluation of liquid chromatography analytical procedures. Journal of Pharmaceutical and Biomedical Analysis, 171, 73-80. doi:10.1016/j.jpba.2019.04.005
    • NLM

      Separovic L, Lourenço FR. Measurement uncertainty and risk of false conformity decision in the performance evaluation of liquid chromatography analytical procedures [Internet]. Journal of Pharmaceutical and Biomedical Analysis. 2019 ; 171 73-80.[citado 2024 jun. 24 ] Available from: https://doi.org/10.1016/j.jpba.2019.04.005
    • Vancouver

      Separovic L, Lourenço FR. Measurement uncertainty and risk of false conformity decision in the performance evaluation of liquid chromatography analytical procedures [Internet]. Journal of Pharmaceutical and Biomedical Analysis. 2019 ; 171 73-80.[citado 2024 jun. 24 ] Available from: https://doi.org/10.1016/j.jpba.2019.04.005
  • Source: Journal of Pharmaceutical and Biomedical Analysis. Unidades: FCF, FFCLRP

    Subjects: TERAPIA FOTODINÂMICA, NANOPARTÍCULAS, FLUORESCÊNCIA, CROMATOGRAFIA LÍQUIDA, FARMACOCINÉTICA

    Acesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      OLIVEIRA, Líliam Teixeira et al. HPLC-FLD methods to quantify chloroaluminum phthalocyanine in nanoparticles, plasma and tissue: application in pharmacokinetic and biodistribution studies. Journal of Pharmaceutical and Biomedical Analysis, v. 56, n. 1, p. 70-77, 2011Tradução . . Disponível em: https://doi.org/10.1016/j.jpba.2011.04.016. Acesso em: 24 jun. 2024.
    • APA

      Oliveira, L. T., Garcia, G. M., Kano, E. K., Tedesco, A. C., & Mosqueira, V. C. F. (2011). HPLC-FLD methods to quantify chloroaluminum phthalocyanine in nanoparticles, plasma and tissue: application in pharmacokinetic and biodistribution studies. Journal of Pharmaceutical and Biomedical Analysis, 56( 1), 70-77. doi:10.1016/j.jpba.2011.04.016
    • NLM

      Oliveira LT, Garcia GM, Kano EK, Tedesco AC, Mosqueira VCF. HPLC-FLD methods to quantify chloroaluminum phthalocyanine in nanoparticles, plasma and tissue: application in pharmacokinetic and biodistribution studies [Internet]. Journal of Pharmaceutical and Biomedical Analysis. 2011 ; 56( 1): 70-77.[citado 2024 jun. 24 ] Available from: https://doi.org/10.1016/j.jpba.2011.04.016
    • Vancouver

      Oliveira LT, Garcia GM, Kano EK, Tedesco AC, Mosqueira VCF. HPLC-FLD methods to quantify chloroaluminum phthalocyanine in nanoparticles, plasma and tissue: application in pharmacokinetic and biodistribution studies [Internet]. Journal of Pharmaceutical and Biomedical Analysis. 2011 ; 56( 1): 70-77.[citado 2024 jun. 24 ] Available from: https://doi.org/10.1016/j.jpba.2011.04.016

Digital Library of Intellectual Production of Universidade de São Paulo     2012 - 2024